Treace Medical Concepts Inc (NAS:TMCI)

$ 8.55 -0.23 (-2.62%) Market Cap: 532.64 Mil Enterprise Value: 534.29 Mil PE Ratio: 0 PB Ratio: 5.06 GF Score: 40/100

Q3 2024 Treace Medical Concepts Inc Earnings Call Transcript
Nov 05, 2024

$5.76 (+6.08%)

Earnings
Q2 2024 Treace Medical Concepts Inc Earnings Call Transcript
Aug 06, 2024

$6.66 (+5.21%)

Earnings
Q1 2024 Treace Medical Concepts Inc Earnings Call Transcript
May 07, 2024

$11.12 (-0.80%)

Earnings
Q4 2023 Treace Medical Concepts Inc Earnings Call Transcript
Feb 27, 2024

$14.38 (+0.35%)

Earnings
Treace Medical Concepts Inc at JPMorgan Healthcare Conference Transcript
Jan 09, 2024
Q3 2023 Treace Medical Concepts Inc Earnings Call Transcript
Nov 09, 2023

$10 (-6.72%)

Earnings
Treace Medical Concepts Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2023
Treace Medical Concepts Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript
Aug 16, 2023
Q2 2023 Treace Medical Concepts Inc Earnings Call Transcript
Aug 08, 2023

$20.13 (-2.94%)

Earnings
Treace Medical Concepts Inc at Bank of America Global Healthcare Conference Transcript
May 10, 2023
Q1 2023 Treace Medical Concepts Inc Earnings Call Transcript
May 08, 2023

$25.97 (-1.89%)

Earnings
Q4 2022 Treace Medical Concepts Inc Earnings Call Transcript
Mar 07, 2023

$20.23

Earnings
Treace Medical Concepts Inc at JPMorgan Healthcare Conference Transcript
Jan 11, 2023
Q3 2022 Treace Medical Concepts Inc Earnings Call Transcript
Nov 08, 2022

$20.45 (-2.99%)

Earnings
Treace Medical Concepts Inc To Host Surgeon Advisor Event Call Transcript
Sep 20, 2022
Treace Medical Concepts Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022
Q2 2022 Treace Medical Concepts Inc Earnings Call Transcript
Aug 09, 2022

$18.57 (-5.78%)

Earnings
Q1 2022 Treace Medical Concepts Inc Earnings Call Transcript
May 05, 2022

$18.01 (-5.56%)

Earnings
Q4 2021 Treace Medical Concepts Inc Earnings Call Transcript
Mar 03, 2022

$20.41 (-1.31%)

Earnings
Treace Medical Concepts Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2022
Q3 2021 Treace Medical Concepts Inc Earnings Call Transcript
Nov 04, 2021

$24.23 (+0.79%)

Earnings
Treace Medical Concepts Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 14, 2021
Q2 2021 Treace Medical Concepts Inc Earnings Call Transcript
Aug 05, 2021

$28.12 (+0.04%)

Earnings
Q1 2021 Treace Medical Concepts Inc Earnings Call Transcript
May 25, 2021

$28.09 (-0.53%)

Earnings

Q3 2022 Treace Medical Concepts Inc Earnings Call Transcript

Nov 08, 2022 / 09:30PM GMT

Release Date Price: $20.45 (-2.99%)

Transcript 10-Q8-K

Vivian Cervantes

Good afternoon, everyone, and welcome to our third quarter 2022 earnings conference call. Participating from the company today will be John Treace, Chief Executive Officer; and Mark Hair, Chief Financial Officer.

During the call, we will offer commentary on our commercial activity and review our third quarter financial results released after the close of the market today, after which, we will host a question-and-answer session. The press release can be found in the Investor Relations section of our website at investors.treace.com. This call is being recorded and will be archived in the Investors section of our website.

Before we begin, we would like to remind you that it is our intent that all forward-looking statements made during today's call will be protected under the Private Securities Litigation Reform Act of 1995. Any statements that relate to expectations or predictions of future events and market trends as well as our estimated results or performance are forward-looking statements. All forward-looking statements are based upon our current estimates and various

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.